SEC Filings Reveal Hidden Details of Trump’s Most-Favored Nation Drug Pricing Agreements with Pharmaceutical Giants.
admin For years, the intersection of pharmaceutical pricing and federal policy has been a battlefield of...
Health
Minnesota report shows large hospitals continue to dominate the 340B drug discount program
The 340B program, created by Congress in 1992, was originally designed to stretch scarce federal...
Novartis Settles Landmark Lawsuit with Henrietta Lacks’ Estate Over Unauthorized Use of HeLa Cells
The global pharmaceutical titan Novartis has reached a confidential settlement with the estate of Henrietta...
Kennedy Expands Control Over Vaccine Policy With New Appointments to Advisory Committee Amid Legal and Administrative Turmoil
In a move that further signals a radical restructuring of the nation’s public health infrastructure,...
Up and down the ladder: The latest comings and goings
As the newly minted Chief Scientific Officer, Conde-Knape will oversee Valo’s integrated drug discovery and...
The Missing Half: Why Men’s Sexual and Reproductive Health Is the Final Frontier in Global Public Health
Every single day, the global health community grapples with a staggering reality: more than one...
Trump Administration Imposes Nationwide Moratorium on New Medical Equipment Suppliers to Combat Massive Medicare Fraud
The Trump administration has officially declared a high-stakes offensive against systemic corruption within the federal...
Xenon’s seizure drug study reads out soon. Here’s what to expect
The legacy of Richard Pops is inextricably linked to the evolution of the CNS market....
Sarepta CEO Doug Ingram will retire after a tumultuous decade
Ingram’s exit is not merely a corporate transition; it is a deeply personal pivot. During...
FDA Rejection of Atara’s Rare Cancer Therapy Sparks Controversy Amid Allegations of Leadership Shift and Internal Reversal.
The experimental therapy for a rare blood cancer was on a seemingly clear path toward...